SCHEMBL10697516

SCHEMBL10697516

CCOc1cc2nc([S+]([O-])Cc3c(C)ccc(C)c3N(C)C)[nH]c2cc1OCC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10701042 0.86 OGT (0.36)
SCHEMBL10700412 0.81 PLG (0.34)
SCHEMBL10700416 0.79 AMY1A (0.31)
SCHEMBL10701638 0.78 MAOB (0.32)
SCHEMBL10699725 0.78 ATP4A (0.33)
SCHEMBL10702652 0.78 OGT (0.37)
SCHEMBL10697900 0.78 MAOB (0.38)
SCHEMBL10700992 0.77 PTGS2 (0.42)
SCHEMBL10701918 0.75 AMY1A (0.36)
SCHEMBL10700413 0.74 OGT (0.36)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0251536-A1 Benzimidazoles, their production, formulation and use as gastric acid secretion inhibitors FISONS plc (GB) 1988-01-07 EP claimed
EP-0280128-A2 Process for the preparation of 1-(3-azido-2,3-dideoxy-beta-D-erythro-pentofuranoxyl) pyrimidines, and intermediates BAYER AG (DE) 1988-08-31 EP disclosed
EP-0251536-A1 Benzimidazoles, their production, formulation and use as gastric acid secretion inhibitors FISONS plc (GB) 1988-01-07 EP disclosed